Product Description
Basic Info.
Composition: It is a fixed-dose combination of the long-acting amylin analog Cagrilintide and the glucagon-like peptide-1 receptor agonist Semaglutide.
Mechanism of action: Cagrilintide, as an amylin receptor agonist, can significantly suppress appetite and effectively delay gastric emptying; Semaglutide, as a GLP-1 receptor agonist, can significantly enhance insulin secretion and strongly inhibit the release of glucagon.
At the same time, it further slows gastric emptying. The combination of the two is excellent in blood sugar control and weight management.
Factory
Well-Equipped Filter Physical and Chemical Laboratory
To solidify product qualityfoundations and establishan industry-leading r&Dand testing system,the companyinvested in2014to
build a wel-equipped, fully-functional provincial-level filter physical and chemical laboratory. Designed and constructed in strict accor-
dance with the highest national and industry standards, the laboratory is outfitted with world-class precision testing instruments and
experimental equipment.
In 2016, leveraging its exceptional quality management capabilities and standardized production operations, the company successfully
achieved ISO/Ts 16949:2009 certification-the most authoritative quality management system recognized by the global automotive in-
dustry--becoming one of the select few enterprises in the sector to earn this distinguished honor.




















